Biomanufacturing Excellence Act of 2025
Sponsored By: Senator Coons, Christopher A. [D-DE]
Introduced
Summary
National Biopharmaceutical Center of Excellence would be created inside the National Institute of Standards and Technology to accelerate U.S. biopharmaceutical manufacturing and cut reliance on foreign supply chains. It would promote manufacturing innovation, share best practices, enable public-private collaboration, and support worker training to move lab discoveries into commercial production.
Show full summary
- U.S. manufacturers and biotech firms: Would gain access to flexible, affordable development infrastructure to prove scale-up and improve chances of commercializing new medicines.
- Workers and training programs: Would receive support for hands-on training to operate advanced biotechnology tools and build sector talent.
- Public health, agriculture, and defense: Would benefit from stronger domestic manufacturing capacity that the bill ties to better treatment options, food resilience, and military capabilities.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
National Biopharmaceutical Center and Funding
This bill would direct NIST to fund and pick one non‑federal group to run a National Biopharmaceutical Manufacturing Center of Excellence. It would authorize $120,000,000 for fiscal year 2026 to support the Center. The Director would solicit applications and must award a grant or agreement within 180 days of enactment. The Center could use funds for building facilities, research to scale drug manufacturing, and workforce training. The Center would need intellectual property rules before starting and must send reports to Congress at set timelines.
Sponsors & CoSponsors
Sponsor
Coons, Christopher A. [D-DE]
DE • D
Cosponsors
Sen. Budd, Ted [R-NC]
NC • R
Sponsored 11/18/2025
Sen. Padilla, Alex [D-CA]
CA • D
Sponsored 3/11/2026
Sen. Young, Todd [R-IN]
IN • R
Sponsored 3/11/2026
Sen. Tillis, Thomas [R-NC]
NC • R
Sponsored 5/14/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov